Roivant Sciences Ltd

6 lis 2026, 21:03 UTC

Roivant Sciences Ltd is advancing in Friday's session, continuing a trend of gains since Thursday's close, amid unusually high trading volume.

5 lis 2026, 22:02 UTC

Roivant Sciences Ltd is advancing in after-market trading, showing notable strength since Thursday's close and currently positioned well above its 20-day moving average.

4 lis 2026, 21:04 UTC

Roivant Sciences Ltd is sharply higher, exhibiting notable volatility with unusually high market volume, and trading well above its 20-day moving average.

3 lis 2026, 23:16 UTC

Roivant Sciences Ltd's shares are trading modestly higher in after-market hours, recovering from earlier declines while remaining above their 20-day moving average.

2 lis 2026, 20:32 UTC

Roivant Sciences Ltd is declining, reversing a trend of higher daily closes seen recently amid ongoing downward momentum in the market.

30 paź 2026, 19:52 UTC

Roivant Sciences Ltd shares fell as economic data showed a slowdown in business activity, with the Chicago PMI dropping to 55.3 for October.

29 paź 2026, 19:36 UTC

Roivant Sciences announces a six-figure legacy donation to the No Patient Left Behind initiative, enhancing drug affordability and access.

28 paź 2026, 23:02 UTC

Roivant Sciences shares are declining in after-market trading, despite Citigroup raising its price target to $56 and maintaining a Buy rating.

27 paź 2026, 20:07 UTC

Roivant Sciences Ltd shares advanced, stabilizing near the upper end of its one-month range and remaining above its 20-day moving average.

26 paź 2026, 20:01 UTC

Roivant Sciences Ltd shares are declining, pulling back from an early gain amid broader biotechnology sector weakness, with unusually high trading volume today.

23 paź 2026, 20:07 UTC

Roivant Sciences Ltd shares are declining, reflecting broader market trends, despite retracing slightly after a significant dip earlier in the day.

22 paź 2026, 20:07 UTC

Roivant Sciences Ltd shares rose during Thursday's session, showing unusual strength with an early spike before retracing, and remain significantly above their 20-day moving average.

21 paź 2026, 23:41 UTC

Roivant Sciences Ltd is advancing in after-market trading, having gained since Wednesday's close and currently positioned above its 20-day moving average.

20 paź 2026, 20:08 UTC

Roivant Sciences Ltd is trading modestly higher, closing slightly above Monday's close but remains 1.31% below its 20-day moving average.

19 paź 2026, 20:51 UTC

Roivant Sciences Ltd is trading lower in after-market hours, having pulled back from a brief high earlier in the session and remaining below its 20-day moving average.

16 paź 2026, 22:26 UTC

Roivant Sciences Ltd shares traded higher in after-market hours, maintaining a slight increase from earlier lows amid broader market concerns over inflationary pressures.

15 paź 2026, 19:51 UTC

Roivant Sciences Ltd is advancing alongside a broader rise in the Biotechnology sector, as CEO Matt Gline expressed frustration over investor agreements at the #STATSummit.

13 paź 2026, 20:01 UTC

Roivant Sciences Ltd shares fell, diverging from recent gains, amid broader market declines, although Citi placed the company on its positive catalyst watch.

12 paź 2026, 23:56 UTC

Roivant Sciences Ltd is trading higher in after-hours action, having previously peaked before a slight retracement, but remains below its 20-day moving average.

9 paź 2026, 19:51 UTC

Roivant Sciences Ltd shares are advancing today, supported by unusually high trading volume, breaking a recent trend of higher daily closes since Thursday.

8 paź 2026, 20:07 UTC

Roivant Sciences Ltd shares declined amid negative sentiment from parent company Immunovant following caution from H.C. Wainwright regarding IMVT-1402's mid-stage study.

7 paź 2026, 22:02 UTC

Roivant Sciences Ltd saw a notable rise in after-market trading, gaining ground since Wednesday's close, despite being below its 20-day moving average.

6 paź 2026, 20:07 UTC

Roivant Sciences Ltd shares fell sharply, reaching a midday low and remaining significantly below their 20-day moving average.

5 paź 2026, 23:45 UTC

Roivant Sciences Ltd is trading slightly higher in after-market hours, following earlier gains, despite remaining below its 20-day moving average.

2 paź 2026, 22:02 UTC

Roivant Sciences Ltd is experiencing a significant decline in after-market trading, reaching its lowest point of the day amid unusual volatility.

1 paź 2026, 20:31 UTC

Roivant Sciences Ltd is trading higher in after-market hours, continuing its advance since Thursday's close, despite earlier pulling back from a session high.

30 wrz 2026, 21:10 UTC

Roivant Sciences Ltd traded lower in after-market hours, closing at its lowest point of the day and significantly below its 20-day moving average.

29 wrz 2026, 22:35 UTC

Roivant Sciences Ltd saw a slight decline in after-market trading, remaining near the lower end of its one-month range and below its 20-day moving average.

28 wrz 2026, 22:01 UTC

Roivant Sciences Ltd is rising in after-market trading, advancing from a low point shortly after the market closed, though still below its 20-day moving average.

25 wrz 2026, 21:20 UTC

Roivant Sciences Ltd saw a notable increase in after-market trading, recovering from a low point and advancing higher since Friday's close.